• Founded: 2019
  • Location: La Jolla, CA
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Drug types: ONC
  • Product link: https://www.entos.ai/pipeline
  • Funding: $53M A Jul 2021
  • Investors: Coatue, Catalio Capital Management, OrbiMed, Sequoia Capital, Nexus Ventures, Freeflow



job board

Short description:

AI-based Drug Discovery

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

Iambic is using AI to explore novel chemical space for drug discovery. Through the use of AI-driven molecular design and high-throughput experimentation, Iambic has built their platform that unlocks novel chemical matter to find better development candidates. The high throughput experimentation comprises both faster chemical synthesis and biological assays such that many potential candidates can be screened for efficacy. The aim is to find drugs that are safe and highly targeted for patients. Currently, Iambic is building their candidate pipeline with their lead indication approaching Phase 1 trials for HER2 targeting.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com